Key releases are ad hoc announcements pursuant to SIX Swiss Exchange Art. 53 LR
Latest press release
Latest press releases and news stories
Go to news archive
Featured News Article
10/11/2025
News story
ASDS 2025: Galderma’s scientific presentations
05/11/2025
Press release
Galderma receives U.S. FDA approval for Restylane® Lyft™ for the enhancement of the chin profile
29/10/2025
News story
Two patients, one condition: the overlooked impact of atopic dermatitis on families
23/10/2025
Press release
Galderma delivers record net sales of 3.737 billion USD in the first nine months of 2025 and 15.0% year-on-year growth at constant currency, raises full-year guidance
24/09/2025
Press release
AMWC Dubai: Galderma demonstrates Injectable Aesthetics leadership through updates on its scientific innovations and community education
24/09/2025
News story
AMWC Dubai 2025: Galderma’s Scientific Presentations
GALDERMA'S RESPONSE TO AESTHETIC IMPACT OF MEDICATION-DRIVEN WEIGHT LOSS
Discover key insights from the first international consensus guidelines in the full report.
Galderma Annual Reports
MEDIA TOOLKIT: ATOPIC DERMATITIS
Access materials for additional information about the burden of atopic dermatitis.
MEDIA TOOLKIT: PRURIGO NODULARIS
Access materials for additional information about the burden of prurigo nodularis.
MEDIA TOOLKIT: SENSITIVE SKIN AND MODERN LIFESTYLES
Galderma’s scientific response to a growing dermatological challenge.
MEDIA TOOLKIT: MEDICATION-DRIVEN WEIGHT LOSS
Understanding the aesthetic impacts of significant and rapid weight loss.
GET IN TOUCH WITH
25.08.2025
Press release
17.06.2025
Press release
